+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation



Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation



Acc Current Journal Review 14(2): 59-0




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063350039

Download citation: RISBibTeXText

DOI: 10.1016/j.accreview.2004.12.140


Related references

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. Journal of the American College of Cardiology 44(8): 1557-1566, 2004

Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments. Revista Espanola de Cardiologia 64(4): 260-268, 2011

Paroxysmal atrial fibrillation and administration of antiplatelet therapy are still negative determinants of warfarin use in non-valvular atrial fibrillation patients treated by Japanese cardiologists. Circulation Journal 75(10): 2314-2315, 2012

Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation. Journal of the American College of Cardiology 44(8): 1567-1569, 2004

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review. Clinical Cardiology 40(6): 407-412, 2016

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands. Netherlands Heart Journal 24(10): 574-580, 2016

Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study. Medicine 95(14): E3037, 2016

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA Study. Revista Clinica Espanola 217(4): 193-200, 2017

Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry. Clinical and Applied Thrombosis/Hemostasis 21(2): 144-148, 2016

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 35(10): 2362-2367, 2004

The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients. European Journal of Neurology 26(2): E24-E24, 2019

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation. Korean Circulation Journal 47(3): 366-376, 2017

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients. Revista Espanola de Cardiologia 62(9): 972-975, 2010